Prevention of Ischemia/Reperfusion-Induced Accumulation of Matrix Metalloproteinases in Rat Lung by Preconditioning With Nitric Oxide

Journal of Surgical Research

Volumn 152, Issue 2, 2009, Pages 198-208

  Waldow, Thomas ^a   Witt, Wolfgang ^a   Buzin, Anne ^a   Ulmer, André ^a   Matschke, Klaus ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

EMMPRIN; endostatin; ischemia reperfusion; lung; matrix metalloproteinase; nitric oxide; TIMP

Indexed keywords

CD147 ANTIGEN; ENDOSTATIN; GELATINASE A; GELATINASE B; LEUKOCYTE ELASTASE; MATRILYSIN; MATRIX METALLOPROTEINASE 14; MYELOPEROXIDASE; NITRIC OXIDE; PLASMA PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL BLOOD; ARTICLE; CELL INVASION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EXTRAVASATION; ISCHEMIA; ISCHEMIC PRECONDITIONING; LEUKOCYTE; LUNG DISEASE; LUNG LAVAGE; LUNG PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SECRETION; RAT; REPERFUSION INJURY; TISSUE LEVEL; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; GELATINASES; ISCHEMIC PRECONDITIONING; LEUKOCYTE ELASTASE; LUNG; MALE; MATRIX METALLOPROTEINASES; NITRIC OXIDE; PANCREATIC ELASTASE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SUPINE POSITION; THORACOTOMY;

EID: 61849133890     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.03.014     Document Type: Article

References (52)

1. de Perrot M., Liu M., Waddell T.K., et al. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 167 (2003) 490
2. Seal J.B., and Gewertz B.L. Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg 19 (2005) 572
3. Ng C.S.H., Wan S., Arifi A.A., et al. Inflammatory response to pulmonary ischemia-reperfusion injury. Surg Today 36 (2006) 205
4. Cauwe B., Van den Steen P.E., and Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 42 (2007) 113
5. Cummins P.M., von Offenberg Sweeney N., Killeen M.T., et al. Cyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: A force to be reckoned with. Am J Physiol Heart Circ Physiol 292 (2007) H28
6. Van Lint P., and Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 82 (2007) 1375
7. Manicone A.M., and McGuire J.K. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 19 (2008) 34
8. Pardo A., and Selman M. Matrix metalloproteases in aberrant fibrotic tissue remodeling. Proc Am Thorac Soc 3 (2006) 383
9. Greenlee K.J., Werb Z., and Kheradmand F. Matrix metalloproteinases in lung: Multiple, multifarious, and multifaceted. Physiol Rev 87 (2007) 69
10. Nagase H., Visse R., and Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69 (2006) 562
11. Yan C., and Boyd D.D. Regulation of matrix metalloproteinase gene expression. J Cell Physiol 211 (2007) 19
12. Schenk S., and Quaranta V. Tales from the crypt[ic] sites of the extracellular matrix. Trends Cell Biol 13 (2003) 366
13. Mott J.D., and Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol 16 (2004) 558
14. Tabruyn S.P., and Griffioen A.W. Molecular pathways of angiogenesis inhibition. Biochem Biophys Res Commun 355 (2007) 1
15. Soccal P., Gasche Y., Pache J.C., et al. Matrix metalloproteinases correlate with alveolar-capillary permeability alteration in lung ischemia-reperfusion injury. Transplantation 70 (2000) 998
16. Yano M., Omoto Y., Yamakawa Y., et al. Increased matrix metalloproteinase 9 activity and mRNA expression in lung ischemia-reperfusion injury. J Heart Lung Transplant 20 (2001) 679
17. Roach D.M., Fitridge R.A., Laws P.E., et al. Up-regulation of MMP-2 and MMP-9 leads to degradation of type IV collagen during skeletal muscle reperfusion injury; protection by the MMP inhibitor, doxycycline. Eur J Vasc Endovasc Surg 23 (2002) 260
18. Soccal P.M., Gasche Y., Miniati D.N., et al. Matrix metalloproteinase inhibition decreases ischemia-reperfusion injury after lung transplantation. Am J Transplant 4 (2004) 41
19. Steinberg J., Halter J., Schiller H., et al. Chemically modified tetracycline prevents the development of septic shock and acute respiratory distress syndrome in a clinically applicable porcine model. Shock 24 (2005) 348
20. Shimoyama T., Tabuchi N., Chung J., et al. Matrix metalloproteinase inhibitor (ONO-4817) attenuates ischemia-reperfusion injury in rat lung. Med Sci Monit 12 (2006) BR51
21. Cohen M.V., Yang X.M., and Downey J.M. Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardivasc Res 70 (2006) 231
22. Schütte H., Witzenrath M., Mayer K., et al. Short-term "preconditioning" with inhaled nitric oxide protects rabbit lungs against ischemia-reperfusion injury. Transplantation 72 (2001) 1363
23. Cheung P.Y., Sawicki G., Peliowski A., et al. Inhaled nitric oxide inhibits the release of matrix metalloproteinase-2, but not platelet activation, during extracorporeal membrane oxygenation in adult rabbits. J Pediatr Surg 38 (2003) 534
24. Souza-Costa D.C., Zerbini T., Palei A.C., et al. L-arginine attenuates acute pulmonary embolism-induced increases in lung matrix metalloproteinase-2 and matrix metalloproteinase-9. Chest 128 (2005) 3705
25. Hubert B., Troncy E., Gauvin D., et al. Increased alveolar and plasma gelatinases activity during postpump syndrome: Inhibition by inhaled nitric oxide. J Cardiovasc Pharmacol 48 (2006) 71
26. Marcet-Palacios M., Ulanova M., Duta F., et al. The transcription factor Wilms tumor 1 regulates matrix metalloproteinase-9 through a nitric oxide-mediated pathway. J Immunol 179 (2007) 256
27. Okamoto T., Akuta T., Tamura F., et al. Molecular mechanism for activation and regulation of matrix metalloproteinases during bacterial infections and respiratory inflammation. Biol Chem 385 (2004) 997
28. Waldow T., Witt W., Ulmer A., et al. Preconditioning by inhaled nitric oxide prevents hyperoxic and ischemia/reperfusion injury in rat lungs. Pulm Pharmacol Ther 21 (2008) 418
29. Waldow T., Witt W., Weber E., et al. Nitric oxide donor-induced persistent inhibition of cell adhesion protein expression and NFkappaB activation in endothelial cells. Nitric Oxide 15 (2006) 103
30. Atkinson J.J., and Senior R.M. Matrix metalloproteinease-9 in lung remodeling. Am J Respir Cell Mol Biol 28 (2003) 12
31. Opdenakker G., Van den Steen P.E., Dubois B., et al. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 69 (2001) 851
32. Visse R., and Nagase H. Matrix metalloproteineases and tissue inhibitors of metalloproteineases: Structure, function, and biochemistry. Circ Res 92 (2003) 827
33. Siu M.K.Y., and Cheng C.Y. Interactions of proteases, protease inhibitors, and the beta1 integrin/laminin gamma3 protein complex in the regulation of ectoplasmic specialization dynamics in the rat testis. Biol Reprod 70 (2004) 945
34. Lehti K., Lohi J., Valtanen H., et al. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J 334 (1998) 345
35. Heljasvaara R., Nyberg P., Luostarinen J., et al. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases. Exp Cell Res 307 (2005) 292
36. Ohbayashi H. Matrix metalloproteinases in lung diseases. Curr Protein Pept Sci 3 (2002) 409
37. Chakrabarti S., and Patel K.D. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp Lung Res 31 (2005) 599
38. Churg A., and Wright J.L. Proteases and emphysema. Curr Opin Pulm Med 11 (2005) 153
39. Ciccocioppo R., Di Sabatino A., Bauer M., et al. Matrix metalloproteinase pattern in celiac duodenal mucosa. Lab Invest 85 (2005) 397
40. Miller T.L., Shashikant B.N., Pilon A.L., et al. Effects of recombinant Clara cell secretory protein (rhCC10) on inflammatory-related matrix metalloproteinase activity in a preterm lamb model of neonatal respiratory distress. Pediatr Crit Care Med 8 (2007) 40
41. Kawabata K., Hagio T., and Matsuoka S. The role of neutrophil elastase in acute lung injury. Eur J Pharmacol 451 (2002) 1
42. Moraes T.J., Zurawska J.H., and Downey G.P. Neutrophil granule contents in the pathogenesis of lung injury. Curr Opin Hematol 13 (2006) 21
43. Bishop M.J., Chi E.Y., and Cheney Jr. F.W. Lung reperfusion in dogs causes bilateral lung injury. J Appl Physiol 63 (1987) 942
44. Palazzo R., Hamvas A., Shuman T., et al. Injury in nonischemic lung after unilateral pulmonary ischemia with reperfusion. J Appl Physiol 72 (1992) 612
45. Watanabe A., Kawaharada N., Kusajima K., et al. Contralateral lung injury associated with single-lung ischemia-reperfusion injury. Ann Thorac Surg 62 (1996) 1644
46. Magi B., Bargagli E., Bini L., et al. Proteome analysis of bronchoalveolar lavage in lung diseases. Proteomics 6 (2006) 6354
47. Candiano G., Bruschi M., Pedemonte N., et al. Proteomic analysis of the airways surface liquid: Modulation by proinflammatory cytokines. Am J Physiol Lung Cell Mol Physiol 292 (2007) L185
48. Gabison E.E., Hoang-Xuan T., Mauviel A., et al. EMMPRIN/CD147, an MMP modulator in cancer, development and tissue repair. Biochimie 87 (2005) 361
49. Haseneen N.A., Vaday G.G., Zucker S., et al. Mechanical stretch induces MMP-2 release and activation in lung endothelium: Role of EMMPRIN. Am J Physiol Lung Cell Mol Physiol 284 (2003) L541
50. Odajima N., Betsuyaku T., Nasuhara Y., et al. Extracellular matrix metalloproteinase inducer in interstitial pneumonias. Hum Pathol 37 (2006) 1058
51. Tang W., Chang S.B., and Hemler M.E. Links between CD147 function, glycosylation, and caveolin-1. Mol Biol Cell 15 (2004) 4043
52. Paddenberg R., Faulhammer P., Goldenberg A., et al. Hypoxia-induced increase of endostatin in murine aorta and lung. Histochem Cell Biol 125 (2006) 497